FDA Adverse Event
Malfunction
Summary report: N
RANDOX LIPOPROTEIN (A) - IN VITRO DIAGNOSTIC (IVD) USE AS RANDOX LIPOPROTEIN (A)
MDR report key: 22161063
·
Received June 6, 2025
Report
- Report Number
- MW5171150
- Event Type
- Malfunction
- Date Received
- June 6, 2025
- Report Date
- May 30, 2025
- Manufacturer
- RANDOX LABORATORIES LIMITED
- Product Code
- DFC
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- IN, US
- Reporter Occupation
- UNKNOWN
- Health Professional
- *
Narratives
Description of Event or Problem · 0
RANDOX DID NOT INFORM MY LABORATORY OF THIS RECALL EVENT (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1265253 | RANDOX LIPOPROTEIN (A) - IN VITRO DIAGNOSTIC (IVD) USE AS RANDOX LIPOPROTEIN (A) | LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL | DFC | RANDOX LABORATORIES LIMITED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |